Related references
Note: Only part of the references are listed.Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis
Cynthia Morata-Tarifa et al.
STEM CELL RESEARCH & THERAPY (2020)
Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: characteristics and risk factors for infectious complications
Igor Stoma et al.
ANNALS OF HEMATOLOGY (2018)
Good responses but high TRM in adult patients after MSC therapy for GvHD
U. Salmenniemi et al.
BONE MARROW TRANSPLANTATION (2017)
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study
Manuel Jurado et al.
CYTOTHERAPY (2017)
Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation
G. M. Dotoli et al.
BONE MARROW TRANSPLANTATION (2017)
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
Stephanie J. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells
L. C. J. te Boome et al.
LEUKEMIA (2015)
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
Martino Introna et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease
Lynne M. Ball et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study
Vinod K. Prasad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Have we improved in preventing and treating acute graft-versus-host disease?
Lia Perez et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M. von Bonin et al.
BONE MARROW TRANSPLANTATION (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
The Immunosuppressive Properties of Mesenchymal Stem Cells
Georg Siegel et al.
TRANSPLANTATION (2009)
Current and novel therapies in acute GVHD
Vincent T. Ho et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes
Soraya Tabera et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue
Linyi Peng et al.
STEM CELLS AND DEVELOPMENT (2008)
Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease
B. Fang et al.
TRANSPLANTATION PROCEEDINGS (2007)
Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children
Baijun Fang et al.
PEDIATRIC TRANSPLANTATION (2007)
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Olle Ringden et al.
TRANSPLANTATION (2006)
Treatment of acute graft-versus-host disease with prednisolone:: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
Maria Teresa Van Lint et al.
BLOOD (2006)
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue
Susanne Kern et al.
STEM CELLS (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Fat tissue: an underappreciated source of stem cells for biotechnology
JK Fraser et al.
TRENDS IN BIOTECHNOLOGY (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Duration of immunosuppressive treatment for chronic graft-versus-host disease
BL Stewart et al.
BLOOD (2004)
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
K Le Blanc et al.
EXPERIMENTAL HEMATOLOGY (2003)
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Multilineage cells from human adipose tissue: Implications for cell-based therapies
PA Zuk et al.
TISSUE ENGINEERING (2001)
Share Paper
